Status and trends in glioblastoma lipid metabolism research: a bibliometric analysis

Glioblastoma multiforme (GBM), which is the most lethal brain tumor, exhibits high aggressiveness, recurrence, and poor treatment response. The progression of GBM and resistance to therapy is attenuated by metabolic reprogramming and lipid metabolism. In this study, we conducted a bibliometric analysis of GBM lipid metabolism studies starting from the mid-1990s based on 798 publications from Web of Science Core Collection. In particular, publication trends, geographic and institutional distribution, authorship networks, keyword co-occurrence, and citation bursts, using CiteSpace, VOSviewer, and R-bibliometrix, were examined. Studies published in the US and China increased substantially after 2010. De novo lipogenesis, lipid droplet biology, and treatment targeting of lipid regulatory processes, such as fatty-acid oxidation, were the most frequently studied topics. Recent interest in lipid-immune interactions, ferroptosis, and lipomics suggests that further research is required. This bibliometric overview provides a solid foundation for future studies of GBM lipid metabolism and its clinical translation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-05-30
DOI
https://doi.org/10.1007/s12672-026-05298-1
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Status and trends in glioblastoma lipid metabolism research: a bibliometric analysis

Mavie Katalin Surau, Phillip Alexander Becker, Mohammad Shah Nayaz Burkutally, Wenliang Wang et al.
Discover Oncology
Ferroptosis and cancer prognosis
article

Status and trends in glioblastoma lipid metabolism research: a bibliometric analysis

Mavie Katalin Surau, Phillip Alexander Becker, Mohammad Shah Nayaz Burkutally, Wenliang Wang, Ye Yuan, Yuhang Chen, Fu Xu, Long Chen, Ruohao Sun
article en

Abstract

Glioblastoma multiforme (GBM), which is the most lethal brain tumor, exhibits high aggressiveness, recurrence, and poor treatment response. The progression of GBM and resistance to therapy is attenuated by metabolic reprogramming and lipid metabolism. In this study, we conducted a bibliometric analysis of GBM lipid metabolism studies starting from the mid-1990s based on 798 publications from Web of Science Core Collection. In particular, publication trends, geographic and institutional distribution, authorship networks, keyword co-occurrence, and citation bursts, using CiteSpace, VOSviewer, and R-bibliometrix, were examined. Studies published in the US and China increased substantially after 2010. De novo lipogenesis, lipid droplet biology, and treatment targeting of lipid regulatory processes, such as fatty-acid oxidation, were the most frequently studied topics. Recent interest in lipid-immune interactions, ferroptosis, and lipomics suggests that further research is required. This bibliometric overview provides a solid foundation for future studies of GBM lipid metabolism and its clinical translation.

Discover Oncology
Union Hospital (HK), Capital Medical University (CN), Beijing Tian Tan Hospital (CN), National Clinical Research Center for Digestive Diseases (CN), Essen University Hospital (DE), Wuhan Union Hospital (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), Union Hospital (CN), Huazhong University of Science and Technology (CN), University of Duisburg-Essen (DE)
No poverty
Openalex Percentile: Top 6%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.